Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
about
Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancersGenetic and epigenetic alterations in pancreatic carcinogenesisGenetic abnormalities in pancreatic cancerGenome-wide profiling of methylated promoters in pancreatic adenocarcinoma.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsPrecursor lesions of pancreatic cancer.Molecular signatures of pancreatic cancer.A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancerK-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking.Detection of bladder cancer using novel DNA methylation biomarkers in urine sedimentsFolate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies.Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.Advances in biomarker research for pancreatic cancer.Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.Epigenetics and epigenetic alterations in pancreatic cancer.Genetic and epigenetic alterations of familial pancreatic cancers.MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.The promise of epigenomic therapeutics in pancreatic cancerCpG island methylation profile of pancreatic intraepithelial neoplasia.Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma.Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
P2860
Q21134689-3758A90E-875F-4518-AD82-A906DEEF4812Q24598655-14EF5F9A-5BAE-43FF-92CB-E72519E019E8Q24800194-559932BF-9617-45E9-B5FA-B305D1016704Q30491042-F92C2DB1-B60C-4923-AECF-D7F358BE5A8FQ33801377-C404DBCE-25F5-4221-A1BD-264634071ADFQ33855814-F940E676-C420-4876-A790-6C9345540F0EQ33918801-82ACB239-3C27-493B-A189-65EBA10AFB7FQ34293192-222CFC37-FE8A-40AD-B8C1-DA715348AF11Q34449043-632D3C1C-2BA5-4F54-8A28-99F462622D0AQ34596601-78FEA21F-917E-4C5A-833E-7240C1A3D7A1Q35093755-02B18AFC-7FC3-4979-9CB5-CEA3671DE324Q35626572-A80D48BE-9D8C-4075-B2F0-D440F039CCBCQ35748110-14960A2B-BB91-4CDA-B5F0-91B8EDD6ADE9Q35792134-DA70FF26-6D15-4B3A-8F92-9B7878DAB009Q36108445-C898AFD3-46D4-4EB8-835C-B0D14A0F9339Q36126609-867FAE67-132F-4B94-BE23-C082DD75EF9EQ36614480-C92AB32D-72DB-468B-8CE5-BEF2E852254DQ36670990-56E92784-89C3-4D53-B336-B08D19F182F6Q37041763-F4FF7015-C8D3-437E-A6CD-70C13E55D4BDQ37148201-EF79929C-5512-4FB4-819D-043D761653AFQ37692456-0B3ACD29-5366-4286-ACDC-B698DD1C22F4Q38722321-C6FED67A-502D-492F-8032-28162B6CED9AQ41473804-D1881A28-5225-4E82-AD16-F4021AA1D4B7Q42053166-C6CA1476-CEEE-43B5-BA13-5E873E015CF1Q42115029-F0429BB0-B786-4429-A643-A6228C03539AQ47162128-D63D5B2E-DCA5-4A9F-9BA6-C795A41DB41AQ47615275-CE7554E5-9856-42E7-B90E-75CF159E7738
P2860
Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Identification and characteriz ...... lands in pancreatic carcinoma.
@en
Identification and characteriz ...... lands in pancreatic carcinoma.
@nl
type
label
Identification and characteriz ...... lands in pancreatic carcinoma.
@en
Identification and characteriz ...... lands in pancreatic carcinoma.
@nl
prefLabel
Identification and characteriz ...... lands in pancreatic carcinoma.
@en
Identification and characteriz ...... lands in pancreatic carcinoma.
@nl
P2093
P1433
P1476
Identification and characteriz ...... lands in pancreatic carcinoma.
@en
P2093
P304
P407
P577
2001-12-01T00:00:00Z